| Cancer |
|
" Do not follow where the path may lead. Go instead where there is no path and leave a trail." Ralph Waldo Emerson | |
![]() |
|


















| Cancer |
CD Scan click here CD Ratiometer click here CD Map click here Our Facility click here Mediscience Technology is a multifacited Medical research and development company combining several fields of science and medicine together to create cutting edge medical devices. The Company has developed three prototype products that employ its technology for cancer Diagnosis; they include the Cancer Detection ("CD") Scan, CD Ratiometer and CD Map. These devices use lamp light to provide a broad spectrum of safe, scanning excitation light wavelengths to insure that the appropriate target tissue molecules fluoresce sufficiently to provide maximum diagnostic sensitivity. A fiberoptic probe is attached to each of our devices to transmit the optical excitation signal and to retrieve the native fluorescence response. We believe that the CD instruments have a great deal of versatility and a broad range of potential alternative applications depending on the preferred configuration of the fiberoptic probe. For example, the fiberoptic probe can be configured as a convenient hand held probe for easy-to-access areas such as the oral cavity or the skin surface, or the optical fiber can be fed down the working channel of a rigid or flexible endoscope for assessment of the upper or lower GI tract, through a cystoscope for study of the urinary tract, a colposcope for gynecological evaluation or a laparoscope for evaluation of internal organs, and even through a core biopsy needle to optically assess breast tumors or other deep tissue tumors, such as sometimes occur in the pancreas, liver or prostate.
The CD Scan product prototype is oriented to medical research. It is designed to provide optical scanning capability over a broad spectrum of optical wavelengths for evaluation of tissue. We use the CD Scan whenever possible to help define the critical scanning and emission wavelengths for our two other prototype products.
We are designing the CD Ratiometer as a simple, compact instrument with user friendly features and characteristics. It is being designed to optically assess the scanned tissue only at pre-established optical wavelengths and to instantaneously report out a "yes "no" or "maybe" result viewed on a crt screen. We expect that the CD Ratiometer with its anticipated assortment of disposable probe designs, will be the preferred product for medical practitioners to use in the office or clinical setting.
The CD Map is a vision instrument that is being designed to optically interrogate an area of tissue rather than selective individual points. Although it is at an earlier stage of design than either the CD Scan or CD Ratiometer, it is expected to report out similar results but in the form of a colored map viewed on a crt screen distinguishing normal areas from abnormal areas via color differentiation. If we can successfully develop the CD Map, we expect it to be especially useful in assisting cancer surgeons in clearly defining the surgical margins of tumors, real time during cancer surgery without the use of extrinsic dyes, drugs or other invasive agents.
A lease agreement, dated January 19, 1997 with City College providing for 900 square feet of space as an "incubator" in which prototypes of the products have been designed and assembled by MPL staff working in concert with personnel from an engineering design firm engaged by the Company The objective of the MPL (Mediphotonics Laboratory) is to research the use of light and ultra fast laser technology for cancer diagnosis and therapeutic purposes. The major projects of the MPL have been the development of the Company's prototype products, CD Scan, CD ratiometer and CD Map, including the enhancement of fiberoptic attachments to enable devices to be used with various types of endoscopes and core biopsy needles. The MPL has additionally conducted in-vitro preclinical evaluation of various tissues to determine the most appropriate excitation and emission wavelengths for use with a device for different types of human tissue and cancers, assembled the prototype CD products for use in vivo for human clinical trials and created the algorithms and computer software necessary for the accurate performance of the instruments. |